Journal of Depression And Therapy

Journal of Depression And Therapy

Journal of Depression And Therapy – Copyright License

Open Access & Peer-Reviewed

Submit Manuscript

Copyright License

Clear rights and permissions to support open access mental health research.

CC BY 4.0 Licensing for Depression and Therapy Research

Authors retain copyright while enabling reuse with attribution.

Open licensing accelerates clinical and public health impact.

Author RightsCopyright stays with the authors.
Open ReuseReaders can share and adapt with attribution.
Clinical ImpactEducation and practice benefit quickly.
Compliance ReadyMeets funder open access policies.

Journal at a glance: ISSN 2476-1710 | DOI Prefix 10.14302/issn.2476-1710 | License CC BY 4.0 | Peer reviewed, open access journal.

License Overview

Journal of Depression and Therapy publishes under the Creative Commons Attribution 4.0 (CC BY 4.0) license. Authors retain copyright while granting readers the right to reuse, share, and adapt the work with proper attribution.

This license supports broad dissemination of mental health research while protecting author credit and integrity.

What Authors Retain
  • Copyright ownership of the published work
  • The right to share accepted manuscripts in repositories
  • Ability to reuse figures or content in future works
  • Recognition through required attribution in all reuse
What Readers Can Do
  • Read, download, and share articles without restriction
  • Reuse figures or data with attribution
  • Translate or adapt content for educational use
  • Build upon findings for research or policy applications
Permissions Checklist
  • Obtain written permission for third party figures or scales
  • Provide attribution statements for adapted materials
  • Confirm patient consent for identifiable images or recordings
  • Disclose funding requirements that affect licensing
  • List any trademarked tools or assessments used in therapy studies
Reuse Scenarios

CC BY 4.0 supports clinical training, public health education, and policy translation. The editorial office can help resolve licensing questions at [email protected].

Questions About Licensing?

We can help clarify permissions for your submission.